ozone has been researched along with nov 002 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullaev, IA | 2 |
1 trial(s) available for ozone and nov 002
| Article | Year |
|---|---|
[Application of ozonated perftoran in the treatment of spreaded peritonitis].
Topics: Adolescent; Adult; Aged; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Fluorocarbons; Humans; Injections, Intraperitoneal; Injections, Intravenous; Middle Aged; Oligopeptides; Ozone; Peritonitis; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
1 other study(ies) available for ozone and nov 002
| Article | Year |
|---|---|
[Impact of a combined application of ozonized perftoran and glutoxim on the immune status of the patients and the cytokines profile in extended peritonitis].
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Blood Substitutes; Case-Control Studies; Drug Therapy, Combination; Female; Fluorocarbons; Humans; Immunity, Innate; Immunologic Factors; Interleukin-4; Interleukin-8; Male; Middle Aged; Oligopeptides; Ozone; Peritonitis; Severity of Illness Index; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2014 |